Twelve-month efficacy and safety of omidenepag isopropyl, a selective EP2 agonist, in open-angle glaucoma and ocular hypertension: the RENGE study
Makoto Aihara, Fenghe Lu, Hisashi Kawata, Akihiro Iwata, Noriko Odani‐Kawabata
Topics & Concepts
Open angle glaucomaOcular hypertensionIsopropylAgonistGlaucomaMedicineOphthalmologyInternal medicineChemistryReceptorMedicinal chemistryGlaucoma and retinal disordersRetinal Diseases and TreatmentsCorneal surgery and disorders